🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GE Healthcare has recently submitted a New Drug Application (NDA) for Ioben...
Status
Approved For Marketing
Location
GE Healthcare
Start Date
TBD
Trial ID
NCT00730444
Treatments Being Tested
Objective: The objective of this pilot study is to characterize the cardiac...
Status
Completed
Location
University of Pittsburgh Medical Center
Start Date
2011-09
Trial ID
NCT01432626
Treatments Being Tested
The aim of the study was to assess the reproducibility of quantitative meas...
Status
Completed
Location
GE Healthcare
Start Date
2013-08
Trial ID
NCT01936649
Treatments Being Tested
This study aims to show that 3-dimensional PET/CT imaging with a new novel ...
Status
Completed
Location
University College London Hospital
Start Date
2014-02
Trial ID
NCT02043899
Treatments Being Tested
Some patients are at risk for life-threatening fast heart rates. These can ...
Status
Completed
Location
University of Maryland Medical Center, EP Lab, Rm. N3W77
Start Date
2010-03
Trial ID
NCT01250912
Treatments Being Tested
The goal of this prospective observational study is to evaluate the diagnos...
Status
Recruiting
Location
Nanjing First Hospital
Start Date
2022-07-10
Trial ID
NCT07064746
Treatments Being Tested
This study is being done with a radioisotope, 123I-mIBG (Adreview), to deve...
Status
Completed
Location
University of Ottawa Heart Institute
Start Date
2013-12
Trial ID
NCT02043522
Treatments Being Tested
Patients with symptomatic atrial fibrillation (AF), a rapid beating of the ...
Status
Completed
Location
University of Ottawa Heart Institute
Start Date
2015-03
Trial ID
NCT02071680
Treatments Being Tested
The goal of this exploratory study is to test whether \[18F\]3F-PHPG can be...
Status
Completed
Location
University of Michigan Rogel Cancer Center
Start Date
2020-10-19
Trial ID
NCT04510311
The study is designed to study the effectiveness of 123I-mIBG as a diagnost...
Status
Completed
Location
GE Healthcare
Start Date
2005-08-02
Trial ID
NCT00126412
Treatments Being Tested